Teneliximab
Teneliximab is a monoclonal antibody designed for the treatment of various autoimmune diseases. It is a type of biopharmaceutical that is developed through recombinant DNA technology.
Mechanism of Action[edit]
Teneliximab works by targeting and inhibiting the function of specific immune cells that are involved in the pathogenesis of autoimmune diseases. It binds to a specific protein on the surface of these cells, preventing them from causing inflammation and damage to the body's own tissues.
Clinical Trials[edit]
Teneliximab has undergone several clinical trials to evaluate its safety and efficacy in treating autoimmune diseases. These trials have shown promising results, with many patients experiencing significant improvement in their symptoms. However, further research is needed to fully understand the long-term effects and potential side effects of this treatment.
Regulatory Status[edit]
As of now, Teneliximab is not yet approved by the FDA or any other regulatory authority. It is currently in the late stages of clinical development, and its approval will depend on the results of these trials.
Potential Uses[edit]
Teneliximab has the potential to be used in the treatment of a wide range of autoimmune diseases, including rheumatoid arthritis, psoriasis, and multiple sclerosis. It may also be useful in treating other conditions that involve an overactive immune response, such as certain types of cancer.
See Also[edit]
 | This medical article is a stub. You can help WikiMD by expanding the page. |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
